Cell-based assays for profiling activity and safety properties of cancer drugs
- 1 November 2006
- journal article
- Published by Elsevier in Journal of Pharmacological and Toxicological Methods
- Vol. 54 (3) , 313-319
- https://doi.org/10.1016/j.vascn.2006.02.014
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cisplatin-Induced Apoptosis Is Enhanced by Hypoxia and by Inhibition of Mitochondria in Renal Collecting Duct CellsToxicological Sciences, 2005
- Use of human-derived liver cell lines for the detection of environmental and dietary genotoxicants; current state of knowledgeToxicology, 2004
- Microtubules as a target for anticancer drugsNature Reviews Cancer, 2004
- Sensitivity and predictivity in immunotoxicity testing: immune endpoints and disease resistanceToxicology Letters, 2004
- Application of the CFU-GM Assay to Predict Acute Drug-Induced Neutropenia: An International Blind Trial to Validate a Prediction Model for the Maximum Tolerated Dose (MTD) of Myelosuppressive XenobioticsToxicological Sciences, 2003
- Apoptosis-based therapiesNature Reviews Drug Discovery, 2002
- Approaches to the evaluation of chemical-induced immunotoxicity.Environmental Health Perspectives, 1995
- Apoptosis as a goal of cancer therapyCurrent Opinion in Oncology, 1994
- Antiproliferative activity of the topoisomerase I inhibitors topotecan and camptothecin, on sub- and postconfluent tumor cell culturesBiochemical Pharmacology, 1994
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994